Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aberrant proteins expressed in skin fibroblasts of Parkinson's disease patients carrying heterozygous variants of glucocerebrosidase and parkin genes

17 Feb 2021

Abstract excerpt

Parkinson's disease (PD) is a neurodegenerative disorder that affects movement, and its development is associated with environmental and genetic factors. Genetic variants in GBA and PARK2 are important risk factors implicated in the development of PD; however, their precise roles have yet to be elucidated. The present study aimed to identify and analyse proteins from the skin fibroblasts of patients with PD...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Botulinum Toxin and Related Neurological Disorders
Share to Lysosomal Storage Disorders Research
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33732455
DOI: 10.3892/br.2021.1412

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aberrant proteins expressed in skin fibroblasts of Parkinson's disease patients carrying heterozygous variants of glucocerebrosidase and parkin genesPMID 33732455Read ↗

Bioinformatics analysis and identification of genes and molecular pathways involved in Parkinson's disease in patients with mutations in the glucocerebrosidase gene.Semantic proximity Read ↗

Proteogenomic network analysis reveals dysregulated mechanisms and potential mediators in Parkinson’s diseaseSemantic proximity Read ↗

Linking a compound-heterozygous Parkin mutant (Q311R and A371T) to Parkinson's disease by using proteomic and molecular approaches.Semantic proximity Read ↗

Altered protein expression pattern in skin fibroblasts from parkin -mutant early-onset Parkinson's disease patientsSemantic proximity Read ↗

The GBA1 K198E Variant Is Associated with Suppression of Glucocerebrosidase Activity, Autophagy Impairment, Oxidative Stress, Mitochondrial Damage, and Apoptosis in Skin Fibroblasts.Semantic proximity Read ↗

SWATH Mass Spectrometry-Based CSF Proteome Profile of GBA-Linked Parkinson’s Disease PatientsSemantic proximity Read ↗

Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.Semantic proximity Read ↗

Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.Semantic proximity Read ↗

Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher diseaseSemantic proximity Read ↗

Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s diseaseSemantic proximity Read ↗

Large-scale proteomics analysis of five brain regions from Parkinson’s disease patients with a GBA1 mutationSemantic proximity Read ↗

Large-scale proteomics analysis of five brain regions from Parkinson’s disease patients with a GBA1 mutationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.